Transcat, Inc. (NASDAQ:TRNS) has earned a consensus broker rating score of 1.33 (Strong Buy) from the three brokers that provide coverage for the company, Zacks Investment Research reports. One analyst has rated the stock with a buy rating and two have given a strong buy rating to the company. Transcat’s rating score has improved by 11.3% from 90 days ago as a result of various analysts’ upgrades and downgrades.
Brokers have set a 12 month consensus price objective of $20.00 for the company and are predicting that the company will post $0.23 earnings per share for the current quarter, according to Zacks. Zacks has also given Transcat an industry rank of 65 out of 265 based on the ratings given to related companies.
Several equities analysts recently weighed in on TRNS shares. Singular Research started coverage on shares of Transcat in a research note on Wednesday, November 15th. They issued a “buy” rating and a $15.30 target price for the company. Zacks Investment Research cut shares of Transcat from a “hold” rating to a “sell” rating in a research note on Wednesday, December 20th. Finally, Roth Capital started coverage on shares of Transcat in a research note on Friday, February 9th. They issued a “buy” rating and a $20.00 target price for the company.
Transcat (NASDAQ:TRNS) last issued its quarterly earnings results on Monday, January 29th. The scientific and technical instruments company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.09. The company had revenue of $40.48 million during the quarter. Transcat had a net margin of 3.24% and a return on equity of 10.03%. equities research analysts forecast that Transcat will post 0.7 EPS for the current year.
In other Transcat news, Director John T. Smith sold 2,000 shares of the firm’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $15.70, for a total transaction of $31,400.00. Following the completion of the sale, the director now owns 33,100 shares of the company’s stock, valued at approximately $519,670. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 8.80% of the stock is currently owned by company insiders.
Institutional investors have recently made changes to their positions in the business. Northern Trust Corp lifted its holdings in Transcat by 9.5% during the 2nd quarter. Northern Trust Corp now owns 18,062 shares of the scientific and technical instruments company’s stock valued at $220,000 after purchasing an additional 1,570 shares during the last quarter. Wedge Capital Management L L P NC bought a new stake in shares of Transcat in the 4th quarter worth approximately $378,000. QCI Asset Management Inc. NY grew its position in shares of Transcat by 31.1% in the 3rd quarter. QCI Asset Management Inc. NY now owns 32,234 shares of the scientific and technical instruments company’s stock worth $437,000 after buying an additional 7,647 shares during the last quarter. Quantum Capital Management bought a new stake in shares of Transcat in the 3rd quarter worth approximately $696,000. Finally, Renaissance Technologies LLC grew its position in shares of Transcat by 118.8% in the 4th quarter. Renaissance Technologies LLC now owns 53,394 shares of the scientific and technical instruments company’s stock worth $761,000 after buying an additional 28,994 shares during the last quarter. 57.12% of the stock is owned by institutional investors and hedge funds.
Transcat Company Profile
Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.